AbCellera Biologics Inc. Annual Operating Margin in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
AbCellera Biologics Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2023.
  • AbCellera Biologics Inc. Operating Margin for the quarter ending June 30, 2024 was -815 %, a 917% decline year-over-year.
  • AbCellera Biologics Inc. annual Operating Margin for 2023 was -624 %, a 1499% decline from 2022.
  • AbCellera Biologics Inc. annual Operating Margin for 2022 was 44.6 %, a 18.1% decline from 2021.
  • AbCellera Biologics Inc. annual Operating Margin for 2021 was 54.5 %, a 18.6% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -624 -668 -1499% Jan 1, 2023 Dec 31, 2023
2022 44.6 -9.88 -18.1% Jan 1, 2022 Dec 31, 2022
2021 54.5 -12.4 -18.6% Jan 1, 2021 Dec 31, 2021
2020 66.9 +102 Jan 1, 2020 Dec 31, 2020
2019 -35.5 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.